Author:
Pando-Sandoval Ana,Ruano-Ravina Alberto,Torres-Durán María,Dacal-Quintas Raquel,Valdés-Cuadrado Luis,Hernández-Hernández Jesús R.,Consuegra-Vanegas Angélica,Candal-Pedreira Cristina,Varela-Lema Leonor,Fernández-Villar Alberto,Pérez-Ríos Mónica
Abstract
AbstractIt is not known whether residential radon exposure may be linked to the development of chronic obstructive pulmonary disease (COPD) and/or have an influence on the functional characteristics or exacerbations of COPD. The aim of this study was therefore to ascertain whether there might be an association between residential radon concentrations and certain characteristics of COPD. We analyzed COPD cases drawn from a case–control study conducted in an area of high radon exposure. Data were collected on spirometric pulmonary function variables, hospital admissions, and smoking. Radon measurements were taken using alpha-track-type CR-39 detectors individually placed in patients’ homes. All statistical analyses were performed using the IBM SPSS v22 computer software program. The study included 189 COPD cases (79.4% men; median age 64 years). The median radon concentration was 157 Bq/m3. No differences were found between radon concentration and sex, age or severity of breathing obstruction as measured by FEV1%. It should be noted, however, that 48.1% of patients with FEV1% < 50 had radon concentrations below 100 Bq/m3, as compared to 35.6% with the same severity of obstruction who had over 300 Bq/m3. COPD cases with radon concentrations higher than > 600 Bq/m3 exhibited no different characteristics in lung function. Exposure to radon does not appear to have an influence on the clinical characteristics of smokers and ex-smokers with COPD. As exposure to residential radon increases, there is no trend towards a worsening of FEV1%. Further studies are thus needed to analyze this possible association in never-smokers with COPD.
Funder
Sociedad Española de Neumología y Cirugía Torácica
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (2021 Report). https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed 25 November 2020.
2. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380, 2095 (2012).
3. Soriano, J. B. et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch. Bronconeumol. 57, 235 (2021).
4. Anderson, D. O. & Ferris, B. G. Role of tobacco smoking in the causation of chronic respiratory disease. N. Engl. J. Med. 267, 787 (1962).
5. Mannino, D. M. & Buist, A. S. Global burden of COPD: Risk factors, prevalence, and future trends. The Lancet 370, 765 (2007).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献